Man Group PLC Capricor Therapeutics, Inc. Transaction History
Man Group PLC
- $37.6 Billion
- Q2 2024
A detailed history of Man Group PLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Man Group PLC holds 84,654 shares of CAPR stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,654
Previous 72,897
16.13%
Holding current value
$1.64 Million
Previous $494,000
18.42%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
77Shares Held
6.6MCall Options Held
260KPut Options Held
576K-
Black Rock Inc. New York, NY1.63MShares$31.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$30.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA638KShares$12.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny480KShares$9.26 Million0.0% of portfolio
-
State Street Corp Boston, MA401KShares$7.75 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $470M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...